Do you want to read an article? Please log in or register.
Effectiveness and response predictors of omalizumab in a severe allergic asthma population with a high prevalence of comorbidities: the Australian Xolair Registry
Related content
RECOMMENDED
Asthma
Omalizumab Effectiveness in Severe Allergic Asthma with Multiple Allergic Comorbidities: A Post-Hoc Analysis of the STELLAIR Study
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
J Asthma Allergy
Just J, Thonnelier C, Bourgoin-Heck M, Mala L, Molimard M, Humbert M, STELLAIR Investigators.
doi: 10.2147/JAA.S310888
AsthmaCOPD
Omalizumab Treatment Response in a Severe Allergic Asthma Population with Overlapping COPD
Chest.
Maltby S, Gibson PG, Powell H, McDonald VM
doi: 10.1016/
Asthma
Real-life effectiveness of omalizumab in severe allergic asthma above the recommended dosing range criteria
Clin Exp Allergy.
Hew M, Gillman A, Sutherland M, Wark P, Bowden J, Guo M, Reddel HK, Jenkins C, Marks GB, Thien F, Rimmer J, Katsoulotos GP, Cook M, Yang I, Katelaris C, Bowler S, Langton D, Wright C, Bint M, Yozghatlian V, Burgess S, Sivakumaran P, Yan KY, Kritikos V, Peters M, Baraket M, Aminazad A, Robinson P, Jaffe A, Powell H, Upham JW, McDonald VM, Gibson PG
doi: 10.1111/cea.12774.
RECOMMENDED
Asthma
Characterisation of patients with severe asthma in the UK Severe Asthma Registry in the biologic era
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Thorax
Jackson DJ, Busby J, Pfeffer PE, Menzies-Gow A, Brown T, Gore R, Doherty M, Mansur AH, Message S, Niven R, Patel M, Heaney LG, UK Severe Asthma Registry.
doi: 10.1136/thoraxjnl-2020-215168
RECOMMENDED
Asthma
Clinical Determinants of Successful Omalizumab Therapy in Severe Allergic Asthma Patients: 4-Year-Long, Real-Life Observation
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
J Asthma Allergy
Kucharczyk A, Więsik-Szewczyk E, Poznańska A, Jahnz-Różyk K
doi: 10.2147/JAA.S282203
RECOMMENDED
Asthma
Severe Asthma in a General Population Study: Prevalence and Clinical Characteristics
★ 1
Recommended by
Dr Martin Frey, Faculty Member
J Asthma Allergy
Rönnebjerg L, Axelsson M, Kankaanranta H, Backman H, Rådinger M, Lundbäck B, Ekerljung L
doi: 10.2147/JAA.S327659
RECOMMENDED
Asthma
Frequency of Tiotropium Bromide Use and Clinical Features of Patients with Severe Asthma in a Real-Life Setting: Data from the Severe Asthma Network in Italy (SANI) Registry
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
J Asthma Allergy
Puggioni F, Brussino L, Canonica GW, Blasi F, Paggiaro P, Caminati M, Latorre M, Heffler E, Senna G, Severe Asthma Network in Italy (SANI) group.
doi: 10.2147/JAA.S274245
RECOMMENDED
Asthma
Prevalence and Predictors of Uncontrolled Asthma in Children Referred for Asthma and Other Atopic Diseases
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
J Asthma Allergy.
Kansen HM, Le TM, Uiterwaal C, van Ewijk BE, Balemans W, Gorissen D, de Vries E, van Velzen MF, Slabbers G, Meijer Y, Knulst AC, van der Ent CK, van Erp FC
doi: 10.2147/JAA.S231907.
Comorbidity in severe asthma requiring systemic corticosteroid therapy: cross-sectional data from the Optimum Patient Care Research Database and the British Thoracic Difficult Asthma Registry.
Thorax.
Sweeney J, Patterson CC, Menzies-Gown A, Niven RM, Mansur AH, Bucknall C, Chaudhuri R, Price D, Brightling CE, Heaney LG on behalf of the British Thoracic Society Difficult Asthma Network
doi: 10.1136/